Navigation Links
Awards celebrate clinical research that can improve health and alleviate suffering
Date:4/18/2012

understanding and the development of new ways to diagnose, treat, and prevent disease," said NIH Director Francis S. Collins, M.D., Ph.D. "NIH is a major supporter of clinical research and I am delighted to see this important field get the recognition it so richly deserves."

The projects, which tackled difficult health problems and required extensive collaboration, are remarkable for their bold approaches, innovation and potential for alleviating human suffering. In the area of disease prevention, the winning research has made an impact through prevention of complications after bone marrow transplantation, stroke and potentially fatal bacterial infection of implanted medical devices. New therapies were developed for cystic fibrosis, a chronic form of leukemia and a rare lung condition. And new methods were derived for identifying immune system targets of anti-HIV therapies, reducing HIV transmission through early treatment and identifying risk factors for cardiovascular disease.

The top prize was awarded for findings that early treatment with medications can prevent HIV transmission. This provides solid support for global public health policies on HIV and could help save millions of lives. The work was honored with the Herbert Pardes Clinical Research Excellence Award, named for the former president and chief executive officer of New York-Presbyterian Hospital, a physician who is regarded as a champion and visionary in clinical research.

"The tripartite mission of excellence in research, medical education and patient care unites all scientists in academic medical settings in their pursuit of clinical research that will expand the boundaries of medicine, increase the ability to diagnose, treat and prevent disease, and offer patients and their families hope for the future," Pardes said. "I am delighted to be able to advance this vitally important mission and support clinical researchers as they pursue game-changing medical breakthroughs."'/>"/>

Contact: Cherri McGrew
cherrimcgrew@me.com
202-775-0554
Clinical Research Forum
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. International Diabetes Federation awards $2 million to 9 global diabetes research projects
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders
6. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
7. Awards Strengthen Stonhard's Reputation for High-Performing Floors in the World's Most Prominent Pharmaceutical Facilities
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. AADR awards the 2010 Distinguished Mentoring Award to Irwin D. Mandel
10. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... September is Baby Safety Month, and ... labels and stickers to keep little ones' safety top of mind at all times. ... a particular focus. According to the JPMA's Baby Safety Zone website, this year's theme ...
(Date:9/1/2015)... ... 01, 2015 , ... Curly Hair Solutions™ is thrilled to ... anticipated partnership between Curly Hair Solutions™ and Trade Secrets allows for nationwide distribution ... the Curly Hair Solutions™ team could not be more delighted to see their ...
(Date:8/31/2015)... Orange, NJ (PRWEB) , ... September 01, 2015 ... ... the spine to eliminate chronic back pain – once required a long, arduous ... a shorter hospital stay, less pain, less blood loss and minimal muscle damage. ...
(Date:8/31/2015)... ... 31, 2015 , ... Cosmetic Town Journal is an online ... have a successful cosmetic procedure; from publishing encyclopedic medical articles to inform patients ... ready to help. , It is clear that the Cosmetic Town aesthetic surgery ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Southern Vacation Rentals ... has teamed up with fellow South Walton property management company, 360 Blue, ... poverty in remote parts of the world. The two companies will collect any unopened ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3
... , New York, NY, August 24, 2011 Nearly three-quarters (72%) ... their jobs over the last two years said that they ... because of cost, according to a new Commonwealth Fund ... or medical debt, compared to about half (49%) who lost ...
... Aug. 24 (HealthDay News) -- Exclusive breast-feeding of infants ... against developing the itchy skin disorder known as eczema ... an infant receives only breast milk, with no additional ... Exclusive breast-feeding up to 6 months of age is ...
... well as others in Canada and the United Kingdom, ... motion pictures that depict smoking -- leading to thousands ... California, San Francisco (UCSF) researcher has found. According ... those subsidies, along with government inaction on stricter ratings ...
... , TUESDAY, Aug. 23 (HealthDay News) -- A ... to worsen over time and may lead to an increased ... with diastolic dysfunction, which often comes with advancing age, the ... way and is accompanied by elevated filling pressures. The ...
... (IBD), which affects more than 1 million patients in ... by environmental factors, such as bacteria, in people genetically ... the lining of the colon, is one such condition. ... prompted by different cytokines small signaling proteins secreted ...
... Drug Administration,s ruling that Avastin should no longer be ... Phase III clinical trial shows that Avastin significantly increased ... before surgery. At the annual meeting for ... association of clinical oncologists, Harry D. Bear, M.D., Ph.D., ...
Cached Medicine News:Health News:Three-quarters of those who have lost jobs and health insurance are skipping needed health care 2Health News:Three-quarters of those who have lost jobs and health insurance are skipping needed health care 3Health News:Three-quarters of those who have lost jobs and health insurance are skipping needed health care 4Health News:Breast-Feeding Won't Prevent Kids' Eczema, Researchers Say 2Health News:Taxpayer film subsidies promote youth smoking 2Health News:Common Heart Dysfunction Can Help Bring on Heart Failure 2Health News:Novel cytokine protects mice from colitis 2Health News:Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients 2
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... June 9 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced new ... mellitus program at,the American Diabetes Association,s 68th ... company,s proprietary recombinant human,hyaluronidase enzyme (rHuPH20) with ...
... Pivotal Study Highlighted at Recent Arizona Alzheimer,s ... Consortium Annual Conference in Phoenix -, PHOENIX and ... Health Research Institute today announced that they are,actively enrolling patients ... treatment of Alzheimer,s disease. The study will,evaluate the safety and ...
Cached Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3